Haworth, K. B., Arnold, M. A., Pierson, C. R., Finlay, J. L., & Cripe, T. P. (2016). TB-22 IMMUNOLOGIC PROFILING OF PEDIATRIC BRAIN TUMORS SUGGESTS POTENTIAL BIOMARKERS FOR OPTIMAL IMMUNOTHERAPEUTIC TRIAL SELECTION. Neuro Oncol.
Citação norma ChicagoHaworth, Kellie B., Michael A. Arnold, Christopher R. Pierson, Jonathan L. Finlay, and Timothy P. Cripe. "TB-22 IMMUNOLOGIC PROFILING OF PEDIATRIC BRAIN TUMORS SUGGESTS POTENTIAL BIOMARKERS FOR OPTIMAL IMMUNOTHERAPEUTIC TRIAL SELECTION." Neuro Oncol 2016.
MLA citiranjeHaworth, Kellie B., et al. "TB-22 IMMUNOLOGIC PROFILING OF PEDIATRIC BRAIN TUMORS SUGGESTS POTENTIAL BIOMARKERS FOR OPTIMAL IMMUNOTHERAPEUTIC TRIAL SELECTION." Neuro Oncol 2016.
Opozorilo: Ti citati niso vedno 100% točni.